These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7481305)

  • 1. [Antisense oligonucleotides--a new generation of potential drugs].
    Moser HE
    Praxis (Bern 1994); 1995 Sep; 84(38):1055-6. PubMed ID: 7481305
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense technology: commercial implications.
    Hawkins JW
    Antisense Res Dev; 1991; 1(3):283-4. PubMed ID: 1821649
    [No Abstract]   [Full Text] [Related]  

  • 3. Technology evaluation: AVI-4126, AVI BioPharma.
    Stephens AC
    Curr Opin Mol Ther; 2004 Oct; 6(5):551-8. PubMed ID: 15537057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of antisense nucleic acid molecules.
    Opalinska JB; Gewirtz AM
    Sci STKE; 2003 Oct; 2003(206):pe47. PubMed ID: 14583589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of antisense oligonucleotide drug discovery.
    Bennett CF
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):215-24. PubMed ID: 12162703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide technology: from EST to therapeutics.
    Giles RV
    Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides.
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1996; 58(4):359-81. PubMed ID: 8956554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthetic oligonucleotides and their application in gene therapy].
    Iribarren AM
    Medicina (B Aires); 1995; 55(3):263-6. PubMed ID: 8544726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests.
    AIDS Patient Care STDS; 1996 Dec; 10(6):375-6. PubMed ID: 11361558
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal antisense therapy: preclinical models with a clinical future?
    Bitko V; Barik S
    Curr Opin Mol Ther; 2007 Apr; 9(2):119-25. PubMed ID: 17458164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antisense oligonucleotides: a new class of biologically active molecules].
    Uteshev DB; Korostelev SA; Sergeev AV; Uteshev BS
    Eksp Klin Farmakol; 2004; 67(3):76-9. PubMed ID: 15341077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotides and prevention of tumor growth: a different approach and proposal for a new method.
    Yildiz D; Oztas H; Hilal Ates B
    Med Hypotheses; 2005; 64(2):328-32. PubMed ID: 15607566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal antisense oligonucleotides for cancer therapy.
    Siwak DR; Tari AM; Lopez-Berestein G
    Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168
    [No Abstract]   [Full Text] [Related]  

  • 16. QC in antisense oligo synthesis.
    Agris PF; Smith S; Fu C; Simkins SG
    Nat Biotechnol; 2002 Sep; 20(9):871-2. PubMed ID: 12205500
    [No Abstract]   [Full Text] [Related]  

  • 17. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense and RNAi: powerful tools in drug target discovery and validation.
    Lavery KS; King TH
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide therapy in urology.
    Kausch I; Böhle A
    J Urol; 2002 Jul; 168(1):239-47. PubMed ID: 12050550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.